Stephanie N. Shishido

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Simon K. Lo · 4 shared papers, 2024–2025 · strength 0.85
   • Paper Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and… DOI 10.1038/s41698-025-01165-4↗
   • Paper Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered ad… DOI 10.1016/j.canlet.2025.217546↗
   • Paper Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the… DOI 10.1038/s44276-024-00069-3↗
2. Peter Kühn · 4 shared papers, 2024–2025 · strength 0.85
   • Paper Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and… DOI 10.1038/s41698-025-01165-4↗
   • Paper Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered ad… DOI 10.1016/j.canlet.2025.217546↗
   • Paper Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the… DOI 10.1038/s44276-024-00069-3↗
3. Stephen Jacob Pandol · 4 shared papers, 2024–2025 · strength 0.85
   • Paper Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and… DOI 10.1038/s41698-025-01165-4↗
   • Paper Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered ad… DOI 10.1016/j.canlet.2025.217546↗
   • Paper Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the… DOI 10.1038/s44276-024-00069-3↗
4. Nicholas N. Nissen · 2 shared papers, 2024–2025 · strength 0.43
   • Paper Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and… DOI 10.1038/s41698-025-01165-4↗
   • Paper Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery. DOI 10.1038/s41698-024-00521-0↗
5. Srinivas Gaddam · 2 shared papers, 2024–2025 · strength 0.43
   • Paper Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and… DOI 10.1038/s41698-025-01165-4↗
   • Paper Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery. DOI 10.1038/s41698-024-00521-0↗
6. Ruoxiang Wang · 2 shared papers, 2024–2025 · strength 0.42
   • Paper Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered ad… DOI 10.1016/j.canlet.2025.217546↗
   • Paper Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the… DOI 10.1038/s44276-024-00069-3↗
7. Rabindra R. Watson · 1 shared paper, 2025 · strength 0.24
   • Paper Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and… DOI 10.1038/s41698-025-01165-4↗
8. Aurelia Lugea · 1 shared paper, 2025 · strength 0.23
   • Paper Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered ad… DOI 10.1016/j.canlet.2025.217546↗
9. Richard T. Waldron · 1 shared paper, 2025 · strength 0.23
   • Paper Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered ad… DOI 10.1016/j.canlet.2025.217546↗
10. Andrew Eugene Hendifar · 1 shared paper, 2024 · strength 0.19
    • Paper Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery. DOI 10.1038/s41698-024-00521-0↗
11. Arsen Osipov · 1 shared paper, 2024 · strength 0.19
    • Paper Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery. DOI 10.1038/s41698-024-00521-0↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.